Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Ana Cardeña-Gutiérrez"'
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
Immune checkpoint inhibitors (ICIs) have dramatically transformed oncology by prolonging overall survival and yielding better patient tolerance compared to other chemotherapeutic agents. However, numerous questions remain unanswered about the toxicit
Externí odkaz:
https://doaj.org/article/17b0eeead5c148c39e8603b3a1a62ac5
Autor:
Alexandre Chan, Lawson Eng, Changchuan Jiang, Mary Dagsi, Yu Ke, Mary Tanay, Cristiane Bergerot, Niharika Dixit, Ana Cardeña Gutiérrez, Ana I. Velazquez, Farhad Islami, Enrique Soto‐Perez‐de‐Celis
Publikováno v:
Cancer Medicine, Vol 13, Iss 17, Pp n/a-n/a (2024)
Abstract Background The global cancer burden is rising, particularly in low‐ and middle‐income countries (LMIC), highlighting a critical research gap in understanding disparities in supportive care access. To address this, the Multinational Assoc
Externí odkaz:
https://doaj.org/article/f58536f4c6224eb49e4eeea77700443c
Autor:
Alexandre Chan, Yu Ke, Mary Tanay, Mary Dagsi, Cristiane Bergerot, Niharika Dixit, Lawson Eng, Ana Cardeña Gutiérrez, Changchuan Jiang, Ana I. Velázquez, Farhad Islami, Enrique Soto-Perez-de-Celis
Publikováno v:
JCO Global Oncology, Vol , Iss 10 (2024)
PURPOSEThe study aims to explore unmet social needs and sources of financial toxicities in patients as noted by health care professionals and researchers in cancer supportive care, shedding light on potential health disparities.METHODSIn this cross-s
Externí odkaz:
https://doaj.org/article/55003746f20a4e459f2057da7dd75166
Autor:
Juan de la Haba-Rodriguez, Ferran Ferragut Lloret, Maria Angeles Vaz Salgado, Martín Oré Arce, Ana Cardeña Gutiérrez, Jesús García-Donas Jiménez, Carmen Beato Zambrano, Rosa María Rodríguez Alonso, Rafael López López, Nuria Rodriguez Salas
The improvement of molecular alterations in cancer as well as the development of technology has allowed us to bring closer to clinical practice the determination of molecular alterations in the diagnosis and treatment of cancer. The use of multideter
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1daeae95a9d6a42ec3d44587e7d9cc84
https://link.springer.com/content/pdf/10.1007/s12094-022-02817-8.pdf
https://link.springer.com/content/pdf/10.1007/s12094-022-02817-8.pdf
Autor:
Xabier Mielgo-Rubio, Ana Cardeña Gutiérrez, Verónica Sotelo Peña, Maria Virginia Sánchez Becerra, Andrea María González López, Adriana Rosero, Juan Carlos Trujillo-Reyes, Felipe Couñago
Publikováno v:
World journal of clinical oncology. 13(4)
Malignant pleural mesothelioma (MPM) is the most common type of malignant mesothelioma. It is a rare tumor linked to asbestos exposure and is associated with a poor prognosis. Until very recently, patients with advanced or unresectable disease had li
Autor:
Elena García García, Daniel Riado Minguez, Xabier Mielgo Rubio, Mónica Esteban García, Ana Cardeña Gutiérrez
Publikováno v:
Journal of Clinical & Biomedical Research. :1-2
Autor:
Susana Hernando Polo, Diana Moreno Muñoz, Verónica Sotelo Peña, Ana Cardeña Gutiérrez, Andrea María González López, Manuel Ruiz Muñoz, Mónica Esteban García, Maria Virginia Sánchez Becerra, Teresa Robles Bermejo, Elia Pérez Fernández, Clara Olier Garate, Xabier Mielgo Rubio, Alicia Hurtado Nuño, Ruth Martinez Cabañes, Juan Carlos Cámara Vicario
Publikováno v:
F1000Research. 10:534
Background: Colitis is a frequent immune-related toxicity, without any biomarker that may predict its onset. It is endoscopically similar to intestinal inflammatory diseases, where fecal calprotectin (FC) is used as a biomarker to early-detect a rela